Kednapa Thavorn, Emily Thompson, Srishti Kumar, Aliisa Heiskanen, Anubhav Agarwal, Harold Atkins, Risa Shorr, Terry Hawrysh, Kelvin Kar-Wing Chan, Justin Presseau, Daniel A Ollendorf, Ian D Graham, Jeremy M Grimshaw, Manoj Mathew Lalu, Surapon Nochaiwong, Dean A Fergusson, Brian Hutton, Doug Coyle, Natasha Kekre
OBJECTIVES: This study aims to systematically review evidence on the cost-effectiveness of chimeric antigen receptor (CAR)-T therapies for patients with cancer. METHODS: Electronic databases were searched in October 2022 and updated in September 2023. Systematic reviews, health technology assessments and economic evaluations that compared costs and effects of CAR-T therapy in cancer patients were included. Two reviewers independently screened studies, extracted data, synthesized results, and critically appraised studies using the Philips checklist...
April 17, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research